Announcement on Convening the 2025 Annual Performance Briefing
Filed with SSE · · 2 pages · Chinese
Lushang Freda Pharmaceutical Co., Ltd. on 6ix
Earlier from Lushang Freda Pharmaceutical
- Announcement on the Ongoing Risk Assessment Report of Shandong Commercial Group Finance Co., Ltd.
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Resolutions of the 5th Extraordinary Meeting of the 12th Board of Directors in 2025
- Report for Q3 2025
- Announcement on Transfer of 100% Equity in Wholly-owned Subsidiary Shandong Lushang Inzone Commercial Management Co., Ltd. and Related Party Transaction
Later from Lushang Freda Pharmaceutical
- Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Shandong Jurisdiction
- Announcement on Convening the Q1 2026 Performance Briefing
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Implementation of Dividend Distribution for 2025
- Indicative Announcement on Agreement-based Transfer of Certain Company Shares by Controlling Shareholder and Changes in Equity Interests
Follow Lushang Freda Pharmaceutical into a list and get an email when it puts out news.
Follow Lushang Freda Pharmaceutical